BSE filing, BSE: 544169. Summary written from the filing by ALFA Finder's alert engine.
Amkay Products Ltd: key numbers
- Share price
- ₹53.00
- Market cap
- ₹45.87 Cr
- Revenue (annual)
- ₹42.03 Cr
- Net profit (annual)
- ₹2.31 Cr
- P/E (TTM)
- 19.9×Sector 51.1×
- Promoter holding
- 73.44%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amkay Products Ltd
All →Amkay Products Price Movement Clarification
Amkay Products Limited clarified that recent fluctuations in its share price are solely due to market conditions, and it has no undisclosed price-sensitive information.
Amkay Products Annual General Meeting
Amkay Products Limited held its 19th Annual General Meeting on September 30, 2026. The meeting covered the adoption of financial statements and director re-appointment resolutions.
Amkay Products Annual General Meeting
Amkay Products Limited issued a notice for its Annual General Meeting scheduled on September 30, 2026. The agenda includes adopting financial statements and re-appointing a director.
Amkay Products Annual Report
The company has filed its Annual Report for the financial year 2025-26 and the notice for the 19th Annual General Meeting scheduled for September 30, 2026.
Amkay Products Price Movement Clarification
Amkay Products Limited issued a clarification regarding recent share price movement, stating it is market-driven and not due to undisclosed price-sensitive information.
Amkay Products H2 FY26 Results: Net Profit ₹0.3 Cr, Down 80.0% YoY
Amkay Products Ltd reported revenue from operations of ₹19 Cr (-7.8% YoY) and net profit of ₹0.3 Cr (-80.0% YoY) for H2 FY26.
- Key figure
- Net profit ₹0.3 Cr · -80.0% YoY
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.